Cargando…
Therapeutic effect of modified zengye decoction on primary Sjogren’s syndrome and its effect on plasma exosomal proteins
Background: Modified Zengye Decoction (MZD), a traditional Chinese medicine, is an effective treatment for patients with primary Sjögren’s syndrome (pSS). Purpose: To evaluate the efficacy of MZD and investigate its effect on plasma exosomal proteins. Methods: Eighteen pSS patients were treated with...
Autores principales: | Zeng, Yimin, Peng, Xin, Wang, Yun, Hou, Lei, Ma, Wukai, Yang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462528/ https://www.ncbi.nlm.nih.gov/pubmed/36091838 http://dx.doi.org/10.3389/fphar.2022.930638 |
Ejemplares similares
-
Exploring the mechanisms of action of Zengye decoction (ZYD) against Sjogren’s syndrome (SS) using network pharmacology and animal experiment
por: Yu, Jiake, et al.
Publicado: (2023) -
The plasma exosomes from patients with primary Sjögren’s syndrome contain epithelial cell–derived proteins involved in ferroptosis
por: Peng, Xin, et al.
Publicado: (2023) -
Zengye Decoction Attenuated Severe Acute Pancreatitis Complicated with Acute Kidney Injury by Modulating the Gut Microbiome and Serum Amino Acid Metabolome
por: Dai, Xiao-Yu, et al.
Publicado: (2022) -
Anticonstriction Effect of MCA in Rats by Danggui Buxue Decoction
por: Guo, Ying, et al.
Publicado: (2021) -
Systematic analysis and identification of the absorption and metabolic components of Zengye decoction in type 2 diabetic rats by HPLC-ESI-Q-TOF–MS/MS
por: Chang, Shanquan, et al.
Publicado: (2020)